Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Growth hormone plays a crucial role in fat metabolism, breaking down stored fat and using it for energy
Yes, but coverage varies by plan and is often limited to diabetes treatment
This leads to: Reduced appetite and increased feelings of fullness Slowed gastric emptying , meaning food moves more slowly through the digestive system Improved blood sugar regulation through glucose-dependent insulin secretion Decreased glucagon release , which helps control glucose production Because Wegovy significantly affects the gastrointestinal system, digestive side effects are very common , particularly when starting treatment or increasing the dose
It is too early to say whether those signals translate into a different clinical profile or just a broader label, but they are the reason retatrutide is being followed more closely than any other GLP-1 candidate currently in development
